MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 12-06-2025
Insulet Corporation ROE Ratio 2011-2025 | PODD
Annual ROE Ratio Insulet Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.52 | 28.16 | 0.97 | 3.02 | 1.13 | 15.28 | 4.67 | -16.91 | -45.73 | -215.91 | -61.43 | -36.1 | -117.41 | -80.07 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.52 | -215.91 | -34.7 |
Quarterly ROE Ratio Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.46 | 18.06 | 35.41 | 32.34 | 40.88 | 42.49 | 28.53 | 18.21 | 16.99 | 7.23 | -5.98 | -3.28 | -0.75 | 3.0 | 5.84 | -2.91 | -0.97 | -1.55 | 6.46 | 0.95 | 7.53 | 6.12 | 4.12 | 9.65 | 7.73 | 8.0 | 6.64 | 1.56 | -7.44 | -9.65 | -13.74 | -16.93 | -27.05 | -30.52 | -32.27 | -45.74 | -111.54 | -162.25 | -200.92 | -215.91 | -142.1 | -99.45 | -88.86 | -61.43 | -57.0 | -61.15 | -34.87 | -36.1 | -57.16 | -68.19 | -92.51 | -117.41 | -111.66 | -99.95 | -76.95 | -55.39 | -16.39 | -9.77 | -11.9 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 42.49 | -215.91 | -31.57 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
16.96 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
9290.44 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
-70.08 | $ 3.83 | -0.91 % | $ 133 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-10.9 | $ 304.01 | -1.34 % | $ 8.58 B | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
669.04 | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
25.76 | $ 14.41 | -0.69 % | $ 1.14 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
-100.5 | $ 0.95 | 3.18 % | $ 15.3 M | USA |
 |
IRadimed Corporation
IRMD
|
22.15 | $ 96.59 | 0.37 % | $ 1.22 B | USA |
 |
Bruker Corporation
BRKR
|
6.35 | $ 45.43 | 0.66 % | $ 6.77 K | USA |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
28.12 | $ 128.4 | 2.34 % | $ 223 B | USA |
 |
Boston Scientific Corporation
BSX
|
8.48 | $ 92.29 | -0.31 % | $ 136 B | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
4.79 | $ 62.5 | -0.4 % | $ 3.39 B |  Britain |
 |
EDAP TMS S.A.
EDAP
|
-46.5 | $ 2.94 | 2.08 % | $ 110 M |  France |
 |
LENSAR
LNSR
|
-645.91 | $ 11.57 | 0.52 % | $ 133 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
Cutera
CUTR
|
33.31 | - | -10.19 % | $ 1.99 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
|
Cognyte Software Ltd.
CGNT
|
-6.08 | $ 9.66 | -2.03 % | $ 694 M | Israel |
 |
PAVmed
PAVM
|
119.22 | $ 0.32 | -3.03 % | $ 2.31 M | USA |
 |
Second Sight Medical Products
EYES
|
-133.37 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
10.94 | $ 164.01 | -0.86 % | $ 12.3 B | USA |
 |
Profound Medical Corp.
PROF
|
-22.21 | $ 7.49 | 2.11 % | $ 180 M | Canada |
 |
Accuray Incorporated
ARAY
|
-1.96 | $ 1.06 | -0.09 % | $ 109 M | USA |
 |
Quanterix Corporation
QTRX
|
-9.32 | $ 7.38 | -2.38 % | $ 277 M | USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-74.5 | $ 12.57 | -1.1 % | $ 340 M | USA |
 |
FONAR Corporation
FONR
|
8.28 | $ 14.63 | -0.81 % | $ 95.9 M | USA |
 |
AxoGen
AXGN
|
-9.59 | $ 30.14 | -0.82 % | $ 1.33 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
13.76 | $ 40.12 | -1.74 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-10.67 | $ 17.75 | 0.82 % | $ 410 M | USA |
 |
Globus Medical
GMED
|
2.47 | $ 86.64 | -0.06 % | $ 11.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.45 | $ 13.61 | 1.42 % | $ 1.05 B | USA |
 |
Aziyo Biologics
AZYO
|
97.55 | - | 1.37 % | $ 20.5 M | USA |